Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

This study has been completed.
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Emergent BioSolutions Identifier:
First received: February 13, 2009
Last updated: November 21, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: November 20, 2012